Michael Thomas Ropacki
Corporate Officer/Principal chez ORYZON GENOMICS S.A.
Profil
Michael Thomas Ropacki is currently the Chief Medical Officer-CNS at Oryzon Genomics SA and the President at Strategic Global Research & Development.
Previously, he worked as the Director-Clinical Development & Neuroscience at Janssen Research & Development LLC from 2013 to 2016, the Head-Global Medical Affairs at Janssen Alzheimer Immunotherapy from 2011 to 2013, and the Senior Vice President-Clinical Development at MedAvante-ProPhase, Inc. in 2017.
He holds a doctorate degree from Texas Tech University.
Postes actifs de Michael Thomas Ropacki
Sociétés | Poste | Début |
---|---|---|
ORYZON GENOMICS S.A. | Corporate Officer/Principal | 01/02/2021 |
Strategic Global Research & Development | President | - |
Anciens postes connus de Michael Thomas Ropacki
Sociétés | Poste | Fin |
---|---|---|
MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | 01/10/2017 |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Chief Tech/Sci/R&D Officer | 01/02/2016 |
Janssen Alzheimer Immunotherapy | Chief Tech/Sci/R&D Officer | 01/05/2013 |
Formation de Michael Thomas Ropacki
Texas Tech University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Entreprise privées | 4 |
---|---|
Janssen Alzheimer Immunotherapy | |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
MedAvante-ProPhase, Inc. | |
Strategic Global Research & Development |